Literature DB >> 26610073

Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review.

Zachary Farhood1, Rodney J Schlosser1, Madeline E Pearse1, Kristina A Storck1, Shaun A Nguyen1, Zachary M Soler1.   

Abstract

BACKGROUND: The 22-item Sino-Nasal Outcome Test (SNOT-22) is a commonly utilized outcome measure for chronic rhinosinusitis (CRS). However, what constitutes a normal score remains poorly defined. The goal of this study was to evaluate SNOT-22 scores in a control population without CRS and perform a systematic review and meta-analysis of "normal" values.
METHODS: Ninety-nine subjects without CRS were enrolled, with 95 fully completing the SNOT-22 questionnaire. Multivariable linear regression was used to determine whether demographic factors or medical comorbidities influence SNOT-22 scores in a population without CRS. A systematic literature search was performed, identifying studies that evaluated the SNOT-22 in a non-CRS population and estimates for SNOT-22 values were pooled.
RESULTS: Thirty-six males and 59 females were included in the primary analysis with a mean age of 53.4 ± 17.3 years (range, 18-88 years). The mean SNOT-22 score was 16.4 ± 15.2. Asthma (p = 0.003) and depression (p = 0.002) were found to be independent predictors of higher SNOT-22 scores. Thirteen articles were identified in the literature search and 1 was provided via author correspondence, with 10 reporting sufficient data to be included in the meta-analysis. Weighted mean SNOT-22 score was 11 ± 9.4 (n = 1517). Our data differed significantly from published data (mean difference = 5.4; 95% confidence interval [CI], 3.4 to 7.5; p < 0.0001) likely owing to differences in comorbidities.
CONCLUSION: SNOT-22 scores vary in non-CRS populations depending upon the group queried. Asthma and depression are associated with higher SNOT-22 scores and should be considered when determining what constitutes a normal value.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  healthy volunteers; meta-analysis; quality-of-life; sinusitis; validation studies

Mesh:

Year:  2015        PMID: 26610073     DOI: 10.1002/alr.21668

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  10 in total

1.  Moderate OSAS and turbinate decongestion: surgical efficacy in improving the quality of life and compliance of CPAP using Epworth score and SNOT-20 score.

Authors:  A Fiorita; E Scarano; R Mastrapasqua; P M Picciotti; A Loperfido; G Rizzotto; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

2.  Advanced age adversely affects chronic rhinosinusitis surgical outcomes.

Authors:  Kristen L Yancey; Anne S Lowery; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-27       Impact factor: 3.858

3.  Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Authors:  Pooja P Patel; Jing Cui; Katherine N Cahill; Tanya M Laidlaw
Journal:  Clin Exp Allergy       Date:  2021-12-01       Impact factor: 5.018

4.  Acute Exacerbations in Recurrent Acute Rhinosinusitis: Differences in Quality of Life and Endoscopy.

Authors:  Daniel M Beswick; Noel F Ayoub; Jess C Mace; Alia Mowery; Peter H Hwang; Timothy L Smith
Journal:  Laryngoscope       Date:  2019-12-14       Impact factor: 3.325

5.  Low 22-item sinonasal outcome test scores in chronic rhinosinusitis: Why do patients seek treatment?

Authors:  Joshua M Levy; Jess C Mace; Luke Rudmik; Zachary M Soler; Timothy L Smith
Journal:  Laryngoscope       Date:  2016-07-05       Impact factor: 3.325

Review 6.  Debunking Myths: Sinus Headache.

Authors:  Jennifer Robblee; Karissa A Secora
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-20       Impact factor: 5.081

7.  Predictors of sinonasal disease onset, progression, and severity in pediatric cystic fibrosis patients.

Authors:  Michael S Weinstock; Amber D Shaffer; Amanda L Stapleton
Journal:  Am J Otolaryngol       Date:  2021-03-31       Impact factor: 2.873

8.  Correlation Between SNOT-22, Nasal Cytology, and Mood Disorders in Patients With Allergic Rhinitis Treated With a Liposomal Nasal Spray.

Authors:  Maria Lauriello; Vittoria Di Rubbo; Gaia Sinatti; Marina Pasqua; Cinzia Tucci; Gian-Piero di Marco; Stefano Necozione; Alberto Eibenstein
Journal:  Allergy Rhinol (Providence)       Date:  2019-08-01

9.  Quality of Life and Morbidity after Endoscopic Endonasal Skull Base Surgeries Using the Sinonasal Outcomes Test (SNOT): A Tertiary Hospital Experience.

Authors:  Dhaidan M Alshammari; Ali Almomen; Mahmoud Taha; Hussain Albahrna; Shuruq Alshammari
Journal:  Int J Otolaryngol       Date:  2021-05-08

10.  Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status: Deep Learning CT Analysis and Patient-reported Outcomes.

Authors:  Daniel M Beswick; Stephen M Humphries; Connor D Balkissoon; Matthew Strand; Eszter K Vladar; David A Lynch; Jennifer L Taylor-Cousar
Journal:  Ann Am Thorac Soc       Date:  2022-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.